Prediabetes treatment usually starts with lifestyle changes that improve insulin resistance: modest weight loss when needed, regular physical activity, and a sustainable eating pattern. Some people may also be candidates for medication, especially if weight, A1C, or other risk factors are high. Treatment should be guided by a clinician and confirmed with blood testing.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does prediabetes mean?
Prediabetes means blood glucose is higher than normal but not high enough to meet the usual definition of type 2 diabetes. It is not a diagnosis to ignore: the CDC states that prediabetes raises the risk of type 2 diabetes, heart disease, and stroke 1.
How fasting glucose, A1C, and glucose tolerance testing are used
Clinicians commonly use three tests: fasting plasma glucose, A1C, and the oral glucose tolerance test. Fasting plasma glucose looks at blood sugar after not eating; A1C estimates average blood sugar over about 2 to 3 months; and an oral glucose tolerance test checks how the body handles a glucose drink over time 2.
You may hear terms like impaired fasting glucose or impaired glucose tolerance. These describe different patterns of abnormal blood sugar, and they can guide follow-up with your clinician. If you want a deeper guide to numbers, see our article on blood sugar levels and diabetes.
Why prediabetes often has no symptoms
Prediabetes can be present for years without clear symptoms. The CDC notes that it often goes undetected until health problems appear, which is why testing matters when risk factors are present 1.
Why prediabetes raises the risk of type 2 diabetes, heart disease, and stroke
Prediabetes is tied to insulin resistance, a state where muscle, fat, and liver cells do not respond normally to insulin. Over time, the pancreas may not keep up with the extra insulin demand, and blood sugar can rise further 1.
Prediabetes also clusters with other cardiometabolic risks, such as high blood pressure, abnormal cholesterol, fatty liver, and abdominal weight gain. That is why treatment is not just about one lab value; it is about lowering long-term risk 2.
What causes prediabetes?
Insulin resistance is the central driver for many people, but it is not caused by one single habit. Genetics, age, body composition, sleep, medications, pregnancy history, PCOS, and activity level can all affect risk 1.
Insulin resistance in muscle, fat, and liver
Insulin helps move glucose from the blood into cells. When muscle, fat, and liver cells respond less well to insulin, the pancreas often makes more insulin to compensate. If that compensation is not enough, blood sugar rises into the prediabetes range 1.
For a plain-language explanation, our guide to what insulin resistance is walks through the mechanism and common signs.
Why body weight is only one part of the story
Overweight and obesity can raise risk, but they are not the whole story. Some people with a normal body mass index have prediabetes because of genetics, lower muscle mass, visceral fat, sleep disruption, medications, or family history 1.
Genetics, age, sleep, medications, PCOS, pregnancy history, and family history
The CDC lists several risk factors: age 45 or older, a parent or sibling with type 2 diabetes, physical activity less than 3 times a week, a history of gestational diabetes, giving birth to a baby over 9 pounds, and polycystic ovary syndrome, or PCOS 1. Some groups also carry higher population-level risk because of social, genetic, and access-to-care factors 1.
Can a healthy person be prediabetic?
Yes. A person can exercise, eat mostly whole foods, and still have prediabetes. That does not mean the person did something wrong; it means blood sugar regulation is being affected by one or more risk factors that deserve a careful plan.
What is the fastest safe way to improve prediabetes?
There is no safe overnight fix for prediabetes. The fastest safe path is usually the most consistent one: start activity, reduce high-sugar drinks and refined carbohydrates, improve sleep, and follow up with repeat labs rather than guessing.
Why there is no safe overnight fix
Blood sugar can change day to day, but A1C reflects a longer window. That means a single good week may not fully show up on A1C yet, and a single high reading does not tell the whole story. Clinicians look for patterns and repeat testing when needed 2.
The highest-evidence first steps: activity, food changes, and weight loss when appropriate
The CDC-led National Diabetes Prevention Program focuses on realistic behavior change, including healthier eating, more activity, and weight loss when appropriate 1. The CDC’s commonly cited goals are 5% to 7% weight loss for people with overweight and at least 150 minutes per week of brisk walking or similar activity 1.
A systematic review for the US Preventive Services Task Force found that lifestyle interventions in people with prediabetes or recently diagnosed diabetes improved weight, body mass index, blood pressure, and diabetes incidence outcomes 2.
How quickly blood sugar markers may change, and why follow-up labs matter
Fasting glucose may change sooner than A1C, but follow-up timing depends on the person, baseline values, and treatment plan. Your clinician may repeat fasting glucose, A1C, or another test to confirm whether the pattern is improving, stable, or moving toward diabetes 2.
3-min quiz
Considering weight care as part of a prediabetes plan?
Chia offers clinician-reviewed weight care with compounded semaglutide injection and compounded tirzepatide tablets or injection when clinically appropriate. A licensed US provider reviews your health questionnaire and prescribes only if appropriate; a prescription is not guaranteed. Compounded medications are prepared by state-licensed 503A pharmacies and are not FDA-approved.
What lifestyle treatments have the strongest evidence?
Lifestyle intervention has the strongest first-line evidence for many people with prediabetes. The goal is not a perfect routine; it is a repeatable pattern that improves insulin sensitivity and can be maintained.
Physical activity: brisk walking and resistance training basics
The CDC points to at least 150 minutes per week of brisk walking or similar activity as a practical target 1. Resistance training can also help because muscle is a major place where glucose is used, though the right starting plan depends on fitness level, joint health, and safety.
Nutrition patterns that support blood sugar
Eating patterns that help blood sugar usually have a few things in common: more fiber-rich plants, enough protein, fewer sugary drinks, less refined starch, and mostly unsaturated fats. Mediterranean-style eating is one pattern with evidence for cardiometabolic health, and we cover it in our guide to the Mediterranean diet for prediabetes.
Weight loss targets when a person has overweight or obesity
For people with overweight or obesity, even modest weight loss can improve insulin resistance. The CDC’s 5% to 7% target is often used because it is meaningful but more realistic than extreme weight-loss goals 1.
If insulin resistance makes weight loss harder, our guide on losing weight with insulin resistance explains why progress can feel slower and what to discuss with a clinician.
Sleep, stress, alcohol, and smoking as support factors
Sleep loss, high stress, heavy alcohol use, and smoking can make cardiometabolic risk harder to manage. These areas may not replace food, activity, or medication when needed, but they can support the plan and lower overall risk 2.
When a CDC-recognized Diabetes Prevention Program may help
A CDC-recognized National Diabetes Prevention Program can help people turn goals into weekly habits with a structured curriculum and coaching 1. A randomized trial has also studied an AI-powered lifestyle intervention compared with human coaching in a Diabetes Prevention Program setting, showing that structured support can be delivered in more than one way while still needing clinical oversight 5.
What foods should someone with prediabetes limit or avoid?
For prediabetes, the best food plan is usually a sustainable pattern, not a strict banned-food list. Still, some foods and drinks tend to raise glucose quickly or make portions harder to manage.
Sugary drinks and refined carbohydrates
Sugary drinks are often the first place to look because they add fast-absorbed carbohydrate without much fullness. Refined carbohydrates, such as sweets, white bread, many packaged cereals, and large servings of white rice or pasta, can also raise glucose quickly in some people.
Ultra-processed snacks and large portions of low-fiber starches
Ultra-processed snacks often combine refined starch, added sugar, salt, and fats in a way that makes overeating easier. Low-fiber starches are not forbidden, but portion size and what you pair them with matter.
How to build a plate with protein, fiber, and unsaturated fats
A practical plate often includes a protein source, high-fiber vegetables or beans, a smaller portion of whole-food starch, and unsaturated fat such as olive oil, avocado, nuts, or seeds. This mix can slow digestion and help with fullness.
Why the goal is a sustainable pattern, not a perfect-food list
A rigid plan may work briefly but fail over time. The better question is: what pattern can you repeat most days, enjoy enough to keep, and adjust based on labs? For practical planning, see our prediabetes diet chart.
When might medication be part of prediabetes treatment?
Medication for prediabetes may be considered when risk is higher, when lifestyle steps are not enough, or when obesity treatment is also clinically appropriate. The decision should include benefits, side effects, contraindications, cost, access, pregnancy plans, and follow-up labs.
Metformin: why clinicians sometimes consider it for higher-risk patients
Metformin has evidence for reducing diabetes incidence in people with prediabetes, especially in higher-risk groups 2. It can cause gastrointestinal side effects, and clinicians consider kidney function, B12 status, pregnancy context, and other health factors before prescribing.
Chia does not currently offer metformin. If metformin is the main question, a primary care clinician, endocrinologist, or local diabetes prevention program may be the better fit.
GLP-1 and GIP/GLP-1 medications: where weight treatment may overlap with diabetes prevention
Semaglutide is a GLP-1 receptor agonist; brand examples include Wegovy, Ozempic, and Rybelsus, and compounded semaglutide may be prepared by state-licensed 503A pharmacies when prescribed. In the STEP 10 trial, once-weekly semaglutide 2.4 mg was studied in people with obesity and prediabetes and improved weight and glycemic outcomes compared with placebo; individual results vary 3. Common side effects in GLP-1 studies include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, and clinicians screen for risks such as pregnancy, pancreatitis history, gallbladder disease, and other contraindications.
Tirzepatide is a GIP/GLP-1 receptor agonist; brand examples include Zepbound and Mounjaro, and compounded tirzepatide may be prepared by state-licensed 503A pharmacies when prescribed. A randomized trial of tirzepatide for obesity treatment and diabetes prevention studied people with obesity and prediabetes and reported diabetes-prevention outcomes over long-term follow-up; individual results vary 4. Side effects can include nausea, vomiting, diarrhea, constipation, and abdominal symptoms, and a clinician must review pregnancy status, pancreatitis or gallbladder history, other medications, and overall diabetes risk.
What the evidence does and does not prove
The strongest medication evidence is tied to specific studied products, populations, doses, and follow-up periods. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data, so results from trials of the active ingredient should not be read as guaranteed results for any compounded product.
Liraglutide, a GLP-1 receptor agonist sold under brand names such as Saxenda and Victoza, also has randomized trial evidence over 3 years for weight management and type 2 diabetes risk reduction in people with prediabetes 6. Chia does not currently offer liraglutide.
Why medication decisions should be individualized
A person with mild prediabetes, stable weight, and strong lifestyle habits may need monitoring and support, not medication. A person with obesity, rising A1C, PCOS, gestational diabetes history, or metabolic syndrome may need a broader plan. The right choice depends on the full health picture.
Prediabetes treatment at Chia: where weight care may fit
At Chia, we do not claim to cure prediabetes, and we do not replace primary care diabetes monitoring. Where we may fit is clinician-reviewed weight care for eligible adults when weight is part of the insulin-resistance picture.
How Chia’s online evaluation works
Chia is 100% online. You complete a short health questionnaire, then a licensed US provider reviews it and prescribes only when clinically appropriate. Prescriptions are not guaranteed, dosing is provider-guided, and patients can message their care team through the portal.
Semaglutide at Chia
Chia offers compounded semaglutide injection for weight care, with plans currently starting at $249/month. Microdosing plans are available when provider-guided. Medication is compounded in the US by state-licensed 503A pharmacies and shipped to the patient’s door.
Tirzepatide at Chia
Chia offers compounded tirzepatide tablets and injection, with tablet plans currently starting at $249/month and injection plans currently starting at $299/month. Microdosing plans are available when provider-guided, and prescriptions require a licensed-provider evaluation.
| Chia option | Forms Chia offers | Current starting price | When it may fit | Important limits |
|---|---|---|---|---|
| Semaglutide | Injection | From $249/month | Weight care when a licensed provider finds it clinically appropriate | Not a guaranteed prediabetes treatment; compounded medications are not FDA-approved |
| Tirzepatide | Tablets or injection | Tablets from $249/month; injection from $299/month | Weight care when a licensed provider finds it clinically appropriate; may fit people who prefer tablets or injections | Not a guaranteed prediabetes treatment; compounded medications are not FDA-approved |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/month | People discussing weight care and energy goals with a provider | Not a diabetes-monitoring program; requires clinician review |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | From $329/month | People discussing weight care and muscle-support goals with a provider | Not a diabetes-monitoring program; requires clinician review |
Some patients also ask about Chia protocols such as Weight + Energy or Weight + Muscle. These are weight-care and longevity-oriented protocols, not standalone prediabetes treatment plans.
When Chia may not be the right fit
Chia may not be the right fit if you need a new diabetes diagnosis, urgent symptom evaluation, pregnancy care, complex diabetes medication management, insulin management, or an in-person exam. In those cases, primary care, endocrinology, urgent care, or emergency care may be more appropriate.
Optional patient access path
You can start with Chia’s online eligibility quiz. If you use an AI agent to help organize care, Chia is also reachable through DoctorMCP at mcp.chia.health, but the same rule applies: a licensed clinician must review your health information before any prescription decision.
How do lifestyle treatment, metformin, semaglutide, and tirzepatide compare?
Prediabetes treatment is not one-size-fits-all. Lifestyle treatment is the foundation; medication may be added when risk, weight, labs, and preferences point that way.
| Option | Evidence | Who it may fit | Common limits or risks | Access route |
|---|---|---|---|---|
| Lifestyle intervention | Official CDC guidance and systematic review evidence support structured lifestyle programs for lowering diabetes risk 1, 2 | Most people with prediabetes, especially as a first step | Requires time, support, and follow-up; results vary | Primary care, dietitian, CDC-recognized Diabetes Prevention Program |
| Metformin | Systematic review evidence links metformin with lower diabetes incidence in prediabetes 2 | Some higher-risk patients after clinician review | GI effects, kidney-function considerations, B12 monitoring, pregnancy context | Primary care or endocrinology; Chia does not currently offer metformin |
| Semaglutide | The active ingredient has randomized trial evidence in obesity and prediabetes, including STEP 10 with 2.4 mg once weekly 3 | Some adults where obesity treatment is clinically appropriate | GI side effects; clinician review needed for contraindications; compounded outcomes are not FDA-evaluated | Chia offers compounded semaglutide injection after licensed-provider review |
| Tirzepatide | The active ingredient has randomized trial evidence for obesity treatment and diabetes-prevention outcomes in people with obesity and prediabetes 4 | Some adults where obesity treatment is clinically appropriate | GI side effects; clinician review needed for contraindications; compounded outcomes are not FDA-evaluated | Chia offers compounded tirzepatide tablets or injection after licensed-provider review |
| Liraglutide | The active ingredient has 3-year randomized trial evidence for weight management and type 2 diabetes risk reduction in people with prediabetes 6 | Some adults where liraglutide is selected by a clinician | Daily injection in many labeled uses; GI side effects; contraindications require review | Not currently offered by Chia |
This table compares options at a high level. It is not a ranking, and it is not a dosing plan. Your clinician may also look at blood pressure, cholesterol, kidney function, liver health, family history, medications, and pregnancy plans.
How should someone monitor prediabetes over time?
A1C and fasting glucose are common follow-up tests, but the right schedule depends on your baseline result and risk level. Monitoring matters because prediabetes can improve, stay stable, or progress.
Blood tests to discuss with a clinician
Ask your clinician which tests fit your situation: A1C, fasting plasma glucose, oral glucose tolerance test, lipids, liver enzymes, kidney function, and sometimes insulin-related testing. If symptoms or risk factors change, testing may need to change too 2.
How often follow-up may be considered
Follow-up timing is individualized. Many clinicians repeat labs after a period of lifestyle change or medication adjustment, but exact timing depends on the starting A1C, fasting glucose, medications, and overall risk.
When to seek care sooner
Do not wait for a routine follow-up if you develop severe thirst, frequent urination, unexplained weight loss, vomiting, dehydration, confusion, chest pain, fainting, or trouble breathing. Those symptoms need prompt medical evaluation.
Which prediabetes treatment option fits which person?
The best next step depends on your labs, risk factors, weight history, and access to care. One plan may be enough for one person and too little for another.
| Your situation | Sensible next step to discuss | Why it fits | Trade-off |
|---|---|---|---|
| New prediabetes lab result with no symptoms | Confirm the result and review risk factors with a clinician | Prediabetes is lab-based and often has no symptoms 1 | One test may not tell the whole story |
| Overweight or obesity plus prediabetes | Structured lifestyle plan; discuss weight-care options if appropriate | Weight loss of 5% to 7% is a CDC target for many adults with overweight 1 | Progress takes time and support |
| Prediabetes plus PCOS, gestational diabetes history, or strong family history | More proactive monitoring and a medication discussion | These are recognized risk factors 1 | Medication choice depends on pregnancy plans and other health details |
| Rising A1C despite lifestyle changes | Repeat labs and consider escalation with primary care or endocrinology | Treatment should respond to the trend, not a single number 2 | May need broader testing or in-person care |
| Interested in GLP-1 or GIP/GLP-1 weight care | Licensed-provider evaluation for obesity treatment fit | Semaglutide and tirzepatide have trial evidence in obesity and prediabetes populations 3, 4 | Side effects, contraindications, cost, and compounded-drug limits must be reviewed |
3-min quiz
Start with a clinician-reviewed plan
If weight care may be part of your prediabetes plan, Chia can help you explore whether compounded semaglutide or tirzepatide is clinically appropriate. Complete the online eligibility quiz; a licensed US provider reviews your information, and a prescription is not guaranteed. Chia does not replace primary care blood-sugar monitoring.
Frequently asked questions about prediabetes treatment
Prediabetes can return to the normal blood sugar range for some people, especially with sustained lifestyle changes and weight loss when needed. It can also stay stable or progress, so follow-up testing is important.
There is no safe overnight fix. The fastest safe path is usually consistent action: regular activity, fewer sugary drinks and refined carbs, a sustainable eating pattern, sleep support, and follow-up labs.
Most people do not need a strict banned-food list. It is usually smart to limit sugary drinks, sweets, refined grains, ultra-processed snacks, and large portions of low-fiber starches, while building meals around protein, fiber, and unsaturated fats.
Yes. Prediabetes can happen in people who look healthy or have a normal body weight. Genetics, age, family history, sleep, medications, PCOS, pregnancy history, and visceral fat can all play a role.
Sugar intake can contribute, especially from sugary drinks, but prediabetes is usually more complex. Insulin resistance, genetics, body composition, activity level, sleep, medications, and other health factors can all affect blood sugar.
GLP-1 and GIP/GLP-1 medications are not a universal prediabetes treatment. The active ingredients semaglutide and tirzepatide have been studied in people with obesity and prediabetes, where weight treatment may overlap with diabetes-risk reduction. Compounded drugs are not FDA-approved, and outcomes are not established for compounded formulations.
No. Chia does not currently offer metformin. If metformin is the main question, a primary care clinician or endocrinologist is usually the right place to start.
Some parts of care can happen online, such as lifestyle coaching, weight-care evaluation, and medication follow-up. Blood testing and urgent symptoms still need appropriate clinical care. At Chia, a licensed US provider reviews each health questionnaire and prescribes only when clinically appropriate.
References
- 1.Centers for Disease Control and Prevention. Prediabetes – Your Chance to Prevent Type 2 Diabetes. 2026.
- 2.Jonas DE, Crotty K, Yun JDY, Middleton JC, Feltner C, Taylor-Phillips S, Barclay C, Dotson A, Baker C, Balio CP, Voisin CE, Harris RP. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021.
- 3.McGowan BM, Bruun JM, Capehorn M, et al. Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial. The Lancet Diabetes & Endocrinology. 2024.
- 4.Jastreboff AM, le Roux CW, Stefanski A, et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. The New England Journal of Medicine. 2025.
- 5.Mathioudakis N, Lalani B, Abusamaan MS, et al. An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial. JAMA. 2025.
- 6.le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017.
- 7.Ganeshalingam AA, Uhrenholt N, Arnfred S, et al. Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical Trial. JAMA Psychiatry. 2025.
- 8.Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021.
- 9.Interventions for Reversing Prediabetes: A Systematic Review. 2023.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
